Bell Investment Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.5K Sell
410
-15
-4% -$1.73K 0.01% 283
2026
Q1
$50.8K Buy
425
+8
+2% +$1.05K 0.01% 247
2025
Q4
$56.8K Sell
417
-53
-11% -$7.62K 0.01% 242
2025
Q3
$69.3K Buy
470
+4
+0.9% +$555 0.01% 199
2025
Q2
$60.3K Buy
466
+4
+0.9% +$484 0.01% 219
2025
Q1
$55.2K Buy
462
+4
+0.9% +$496 0.01% 212
2024
Q4
$53.1K Buy
458
+10
+2% +$1.26K 0.01% 213
2024
Q3
$60.5K Hold
448
0.01% 201
2024
Q2
$60.8K Hold
448
0.01% 189
2024
Q1
$57.9K Hold
448
0.01% 189
2023
Q4
$51.2K Buy
448
+27
+6% +$2.69K 0.01% 191
2023
Q3
$38.3K Sell
421
-19
-4% -$1.96K 0.01% 204
2023
Q2
$49.6K Sell
440
-3
-0.7% -$317 0.01% 167
2023
Q1
$46.4K Sell
443
-5
-1% -$522 0.01% 172
2022
Q4
$49.5K Buy
448
+180
+67% +$18.9K 0.01% 164
2022
Q3
$23K Buy
268
+41
+18% +$3.73K 0.01% 244
2022
Q2
$18K Buy
+227
New +$18.7K 0.01% 292
2021
Q4
$32K Buy
267
+9
+3% +$1.12K 0.01% 218
2021
Q3
$32K Buy
+258
New +$33.2K 0.01% 206

Other funds holding XYL

Bell Investment Advisors's XYL Position: Q2 2026 in Review

Bell Investment Advisors reduced its Xylem (XYL) stake by 3.5% in Q2 2026, selling an estimated $1.73K and leaving 410 shares worth $48.5K. The position accounts for 0.01% of the portfolio, ranked #283.

Bell Investment Advisors first reported a position in XYL in Q3 2021 and has held it in 19 quarters since. The position peaked at $69.3K in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Bell Investment Advisors held 410 shares of Xylem worth $48.5K as of Q2 2026.
  • Bell Investment Advisors sold 15 Xylem shares in Q2 2026, an estimated $1.73K.
  • Xylem made up 0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #283 holding.
  • Bell Investment Advisors first reported a position in Xylem in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Xylem position peaked at $69.3K in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.